Sanofi Portfolio Stock Holdings
Sanofi disclosed 9 stock positions valued at approximately $336.0 million in its latest SEC 13F filing. The largest holdings include Inhibrx Biosciences, Inc., Novavax, and AnaptysBio. The filing reflects positions held as of March 31, 2026 and was filed on May 7, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 9
- Portfolio Value
- $336.0M
Holdings by Sector
Sanofi Portfolio Holdings in Q1 2026
6 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| Inhibrx Biosciences, Inc. | INBX | Healthcare | 23.17% | 1,157,926 | - | - | $77,847,365 |
| Novavax | NVAX | Healthcare | 16.67% | 6,880,481 | - | - | $56,007,115 |
| AnaptysBio | ANAB | Healthcare | 9.04% | 821,917 | - | - | $30,384,545 |
| Immuneering Corp | IMRX | Healthcare | 4.25% | 2,708,559 | - | - | $14,274,106 |
| Eledon | ELDN | Healthcare | 0.75% | 814,980 | - | - | $2,510,138 |
| Q32 Bio Inc. | QTTB | Healthcare | 0.47% | 244,083 | - | - | $1,567,013 |